» Articles » PMID: 34506511

Association of Sleep Apnea with Outcomes in Peripheral Artery Disease: Insights from the PORTRAIT Study

Overview
Journal PLoS One
Date 2021 Sep 10
PMID 34506511
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sleep apnea is a predictor of adverse cardiovascular outcome in many cardiovascular diseases but whether it is associated with worse health status outcomes or mortality in peripheral artery disease (PAD) is unknown.

Methods: PORTRAIT is an international (US, Netherlands, Australia) prospective PAD registry that consecutively enrolled patients who presented with new-onset or recent exacerbations of PAD symptoms to any of 16 vascular specialty clinics. Health status was assessed upon presentation and at 12 months with the disease-specific Peripheral Artery Questionnaire (PAQ). Higher PAQ scores indicate better health status. A sequentially-adjusted hierarchical linear regression model examined the association between sleep apnea and 1-year PAQ symptoms, quality of life, and summary scores. Five-year survival curves by comorbid sleep apnea status for US patients were compared using the log-rank test.

Results: The mean age of the 1204 PORTRAIT participants was 67.6 ± 9.4 years with 37.5% women and 8.3% (n = 100) having sleep apnea. Patients with sleep apnea were more likely to be from the US, more sedentary, and to have diabetes, obesity, coronary disease, more depressive symptoms and a history of prior peripheral interventions. Paradoxically, they also had higher ankle-brachial indices, but lower PAQ Summary scores at presentation and 12 months (41.2 ± 22.0 vs. 49. 9± 21.6 and 58.6 ± 27.9 vs. 71.3 ± 24.9, respectively, p = <0.05). The association between sleep apnea and 1-year health status persisted after multivariable adjustment, but there were no differences in all-cause mortality over 5 years (28.0% vs. 23.4%, p = 0.76).

Conclusion: In patients presenting with PAD, comorbid sleep apnea is independently associated with worse health status over time. Future studies should test whether better treatment of sleep apnea can improve the health status of patients with PAD.

Clinical Trial Registration: NCT01419080.

Citing Articles

Psychosocial and socioeconomic factors are most predictive of health status in patients with claudication.

Scierka L, Peri-Okonny P, Romain G, Cleman J, Spertus J, Fitridge R J Vasc Surg. 2024; 79(6):1473-1482.e5.

PMID: 38266885 PMC: 11180544. DOI: 10.1016/j.jvs.2024.01.021.


Dietary Risk Factors and Eating Behaviors in Peripheral Arterial Disease (PAD).

Cecchini A, Biscetti F, Rando M, Nardella E, Pecorini G, Eraso L Int J Mol Sci. 2022; 23(18).

PMID: 36142725 PMC: 9504787. DOI: 10.3390/ijms231810814.


Associations of Chronic Diabetes Complications and Cardiovascular Risk with the Risk of Obstructive Sleep Apnea in Patients with Type 2 Diabetes.

Timofticiuc D, Vladu I, Stefan A, Clenciu D, Mitrea A, Padureanu V J Clin Med. 2022; 11(15).

PMID: 35956020 PMC: 9368962. DOI: 10.3390/jcm11154403.

References
1.
Bradley T, Logan A, Kimoff R, Series F, Morrison D, Ferguson K . Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005; 353(19):2025-33. DOI: 10.1056/NEJMoa051001. View

2.
Mahoney E, Wang K, Cohen D, Hirsch A, Alberts M, Eagle K . One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes. 2009; 1(1):38-45. DOI: 10.1161/CIRCOUTCOMES.108.775247. View

3.
Young T, Peppard P, Taheri S . Excess weight and sleep-disordered breathing. J Appl Physiol (1985). 2005; 99(4):1592-9. DOI: 10.1152/japplphysiol.00587.2005. View

4.
Zhao Y, Wang R, Gleason K, Lewis E, Quan S, Toth C . Effect of Continuous Positive Airway Pressure Treatment on Health-Related Quality of Life and Sleepiness in High Cardiovascular Risk Individuals With Sleep Apnea: Best Apnea Interventions for Research (BestAIR) Trial. Sleep. 2017; 40(4). PMC: 5806548. DOI: 10.1093/sleep/zsx040. View

5.
Kawahara S, Akashiba T, Akahoshi T, Horie T . Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med. 2005; 44(5):422-7. DOI: 10.2169/internalmedicine.44.422. View